NCT03529292 (SKINMAT) is a NA clinical trial of AmeaCell in Skin Aging, sponsored by Symbioken.

Who is sponsoring NCT03529292?

NCT03529292 is sponsored by Symbioken.

What drugs are being tested in NCT03529292?

Interventions in NCT03529292: AmeaCell.

What condition does NCT03529292 study?

NCT03529292 studies Skin Aging.

Is NCT03529292 still recruiting?

NCT03529292 is currently completed. Last updated 6 December 2021.

Last reviewed 2021-12-06 · How we verify

NCT03529292: SKINMAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Study to Evaluate the Safety and the Efficacy of the Matrix and Cells Obtained by the AmeaCell® Device and Intended for the Filling of Wrinkles on the Face.

Completed NA Last updated 6 December 2021

What this trial tests

NA trial testing AmeaCell in Skin Aging in 23 participants. Completed in 1 February 2021.

Timeline

9 July 2018

Primary endpoint
1 February 2021

1 February 2021

Quick facts

Lead sponsor	Symbioken
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	23
Start date	9 July 2018
Primary completion	1 February 2021
Estimated completion	1 February 2021
Sites	1 location across Belgium

Drugs / interventions tested

AmeaCell

Conditions studied

Skin Aging — all drugs for Skin Aging →

Sponsor

Symbioken

Who can join

Adults 18 to 70, any sex, with Skin Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the filling using the Matrix and Cells, obtained by the Ameacell® device from autologous adipose tissue and intended for the filling of wrinkles on the face.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Skin Aging

Currently open trials in the same condition.

NCT07381218 — Focused Ultrasound Treatment for Facial Skin Laxity · NA · active not recruiting
NCT06900660 — Evaluation of the Skin-Beautifying Effects of Collagen Drinks · NA · active not recruiting
NCT06804772 — A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the · NA · active not recruiting
NCT06816069 — Study on Safety and Efficacy of Monopolar Radio Frequency Device for Facial Skin Tightening · NA · active not recruiting
NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03529292 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Symbioken
Last refreshed: 6 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03529292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing